Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib

Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib

Alopecia areata (AA) is a non-scarring hair loss disorder. Alopecia totalis (AT) and alopecia universalis (AU) are the severe subtypes of AA. Age of onset before 6 years of age, disease duration of more than 1 year, and extensive alopecia involving more than 50% of the scalp (including AT or AU) sug...

Full description

Bibliographic Details
Main Authors: Lu Cai, Yi Wei, Min Zhao, Jia Zhuo, Xiao Tao, Mao Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Medicine
Subjects:
alopecia areata
dupilumab
resistant to baricitinib
pediatric patients
Th1
Th2
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1253795/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1253795/full

Similar Items